Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021

SELL
$4.15 - $6.3 $415 - $630
-100 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$3.42 - $6.36 $207,936 - $386,688
-60,800 Reduced 99.84%
100 $0
Q3 2020

Dec 14, 2020

BUY
$2.94 - $12.43 $178,458 - $754,501
60,700 Added 30350.0%
60,900 $210,000
Q4 2019

Jan 24, 2020

SELL
$5.99 - $8.38 $7,787 - $10,894
-1,300 Reduced 86.67%
200 $1,000
Q2 2018

Aug 06, 2018

BUY
$12.76 - $16.94 $19,140 - $25,410
1,500 New
1,500 $22,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0

About Unity Biotechnology, Inc.


  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $22.2M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.